Neumora Therapeutics Investors Sue Over Alleged Securities Law Violations

jueves, 19 de marzo de 2026, 7:30 pm ET1 min de lectura
NMRA--

Neumora Therapeutics, Inc. is under investigation by the Schall Law Firm for potential securities law violations. The firm is investigating claims that the company issued false or misleading statements and/or failed to disclose important information to investors. Shareholders who suffered losses are encouraged to contact the firm for free consultation and potential participation in the investigation.

Neumora Therapeutics Investors Sue Over Alleged Securities Law Violations

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios